Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: A 1-year double-blind RCT in postmenopausal women

Journal of Bone and Mineral Research

Volumn 28, Issue 10, 2013, Pages 2202-2213

  MacDonald, Helen M ^a   Wood, Adrian D ^a   Aucott, Lorna S ^a   Black, Alison J ^b   Fraser, William D ^c   Mavroeidi, Alexandra ^a   Reid, David M ^a   Secombes, Karen R ^a   Simpson, William G ^d   Thies, Frank ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Woolmanhill Hospital   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

bone loss; bone turnover markers; postmenopausal women; randomized controlled trial; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR 23; N TERMINAL PROPEPTIDE OF TYPE 1 COLLAGEN; PARATHYROID HORMONE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; FEMALE; HIP; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; NORMAL HUMAN; OSTEOLYSIS; POSTMENOPAUSE; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME; UNITED KINGDOM; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

BONE LOSS; BONE TURNOVER MARKERS; POSTMENOPAUSAL WOMEN; RANDOMIZED CONTROLLED TRIAL; VITAMIN D;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CHOLECALCIFEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIP; HUMANS; MIDDLE AGED; PARATHYROID HORMONE; POSTMENOPAUSE; VITAMIN D; WITHHOLDING TREATMENT;

EID: 84884416477     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1959     Document Type: Article

References (41)

1. McCollum EV, Simmonds N, Becker JE, Shipley PG., Studies on experimental rickets, XXI: an experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem. 1922; 53: 293-312.
2. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL., Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (review). Cochrane Database Syst Rev. 2009; (2): CD000227.
3. Abrahamsen B, Masud T, Avenell A, Anderson F, Meyer HE, Cooper C, Smith H, LaCroix AZ, Torgerson D, Johansen A, Jackson R, Rejnmark L, Wactawski-Wende J, Brixen K, Mosekilde L, Robbins JA, Francis RM., Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. Br Med J. 2010; 340: b5463.
4. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P., Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007; 92 (4): 1415-23.
5. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J., Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009; 169 (6): 551-61.
6. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B., Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992; 327: 1637-42.
7. Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville J, Francis R, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ., Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. Br Med J. 2005; 330 (7498): 1003.
8. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D., Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006; 354 (7): 669-83.
9. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM., Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res. 1995; 10 (8): 1177-84.
10. Garnero P, Munoz F, Sornay-Rendu E, Delmas PD., Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone. 2007; 40 (3): 716-22.
11. Macdonald HM, Mavroeidi A, Barr RJ, Black AJ, Fraser WD, Reid DM., Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone. 2008; 42 (5): 996-1003.
12. Feskanich D, Willett WC, Colditz GA., Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr. 2003; 77 (2): 504-11.
13. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K., Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int. 2005; 16 (11): 1425-31.
14. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ., Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003; 77 (1): 204-10.
15. Cashman KD, Wallace JM, Horigan G, Hill TR, Barnes MS, Lucey AJ, Bonham MP, Taylor N, Duffy EM, Seamans K, Muldowney S, Fitzgerald AP, Flynn A, Strain JJ, Kiely M., Estimation of the dietary requirement for vitamin D in free-living adults > = 64 y of age. Am J Clin Nutr. 2009; 89 (5): 1366-74.
16. Heaney RP., The effect of vitamin D dose on bone mineral density. Osteoporos Int. 2012; 23 (2): 789-90; author reply 791.
17. Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almas B, Jorde R., The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-a randomized controlled 1-year trial. Osteoporos Int. 2012; 23 (1): 201-11.
18. Gallagher JC, Sai A., Templin T 2nd, Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012; 156 (6): 425-37.
19. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM., Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors. A parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab. 2012; 97 (10): 3557-68.
20. de la Hunty A, Wallace AM, Gibson S, Viljakainen H, Lamberg-Allardt C, Ashwell M., UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr. 2010; 104 (4): 612-9.
21. Fraser WD, Durham BH, Berry JL, Mawer EB., Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann Clin Biochem. 1997; 34 (Pt 6): 632-7.
22. Diffey BL., Ultraviolet radiation dosimetry with polysulphone film. In:, Diffey BL, editor. Radiation measurement in photobiology. London: Academic Press; 1989. p. 135-59.
23. Mavroeidi A, Stewart AD, Reid DM, Macdonald HM., Physical activity and dietary calcium interactions in bone mass in Scottish postmenopausal women. Osteoporos Int. 2009; 20 (3): 409-16.
24. Macdonald HM, Black AJ, Aucott L, Duthie G, Duthie S, Sandison R, Hardcastle AC, Lanham New SA, Fraser WD, Reid DM., Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial. Am J Clin Nutr. 2008; 88 (2): 465-74.
25. Pye SR, Reid DM, Adams JE, Silman AJ, O'Neill TW., Radiographic features of lumbar disc degeneration and bone mineral density in men and women. Ann Rheum Dis. 2006; 65 (2): 234-8.
26. Francis RM, Baillie SP, Chuck AJ, Crook PR, Dunn N, Fordham JN, Kelly C, Rodgers A., Acute and long-term management of patients with vertebral fractures. QJM. 2004; 97 (2): 63-74.
27. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B., Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005; 293 (18): 2257-64.
28. IOM (Institute of Medicine). Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press; 2011.
29. Macdonald HM, Mavroeidi A, Reid DM, Fraser WD., Sunlight or diet: what is the answer for providing sufficient vitamin D in the U.K.?. Br J Dermatol. 2010; 163 (2): 434-5; author reply 435-6.
30. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P., Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab. 1995; 80 (4): 1052-8.
31. Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, Jurutka PW., Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013; 92 (2): 77-98.
32. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB., Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 2003; 64 (6): 2272-9.
33. Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, ter Wee PM., Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol. 2011; 6 (2): 383-9.
34. Powe CE, Ricciardi C, Berg AH, Erdenesanaa D, Collerone G, Ankers E, Wenger J, Karumanchi SA, Thadhani R, Bhan I., Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res. 2011; 26 (7): 1609-16.
35. Holick MF, Vitamin D., importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004; 79 (3): 362-71.
36. Jones G., Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008; 88 (2): 582S-6S.
37. Vieth R., Vitamin D supplementation, 25-hydroxy vitamin D concentrations and safety. Am J Clin Nutr. 1999; 69: 842-56.
38. Haddad JG, Chyu KJ., Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971; 33 (6): 992-5.
39. Vieth R., The pharmacology of vitamin D, including fortification strategies. In:, Feldman D, Glorieux FH, editors. Vitamin D. Burlington, MA: Elsevier Academic Press; 2005. p. 995-1018.
40. Binkley N, Novotny R, Krueger D, Kawahara T, Daida YG, Lensmeyer G, Hollis BW, Drezner MK., Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007; 92 (6): 2130-5.
41. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC., Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010; 303 (18): 1815-22.